Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Price

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent modelDaniel J Price, David H Drewry, Lee T Schaller, et al.
Journal of Medicinal Chemistry|April 3, 2013
Hepatitis C replication inhibitors that target the viral NS4B proteinJohn F Miller, Pek Y Chong, J Brad Shotwell, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Journal of Medicinal Chemistry|April 4, 2020
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry SynthesisThomas J Struble, Juan C Alvarez, Scott P Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent modelDaniel J Price, David H Drewry, Lee T Schaller, et al.
Journal of Medicinal Chemistry|April 3, 2013
Hepatitis C replication inhibitors that target the viral NS4B proteinJohn F Miller, Pek Y Chong, J Brad Shotwell, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Journal of Medicinal Chemistry|April 4, 2020
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry SynthesisThomas J Struble, Juan C Alvarez, Scott P Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Bioorganic & Medicinal Chemistry|October 15, 2020
The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposureRodolfo Cadilla, David N Deaton, Young Do, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
Pageof 5